Search research articles
Contact Us
Filters
Showing results (101-110 of 160) with videos related to
Page
of 16
Sort By:
Human Reproduction (Oxford, England)
|
May 2, 2001
Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development
F P Hohmann, J S Laven, F H de Jong, et al.
Journal of Assisted Reproduction and Genetics
|
April 11, 2001
Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report
D De Jong, E G Van Hooren, N S Macklon, et al.
Clinical Endocrinology
|
November 1, 1992
The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates
B C Fauser, T D Pache, W C Hop, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
July 29, 2009
Diffusion-weighted magnetic resonance imaging in cervical lymphadenopathy: report of three cases of patients with Bartonella henselae infection mimicking malignant disease
D Muenzel, S Duetsch, C Fauser, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 16, 1999
Diagnosis of subtle ovulation disorders in subfertile women with regular menstrual cycles: cost-effective clinical practice?
P van Zonneveld, H P Koppeschaar, J D Habbema, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 16, 1999
Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome
H J Thierry van Dessel, P D Lee, G Faessen, et al.
Acta Endocrinologica
|
August 1, 1993
Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen
D C Schoot, W C Hop, T D Pache, et al.
Endocrinology
|
July 1, 1990
In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines
A B Galway, A J Hsueh, J L Keene, et al.
Human Reproduction (Oxford, England)
|
May 8, 1998
High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization
D de Jong, N S Macklon, B M Mannaerts, et al.
Fertility and Sterility
|
May 1, 1992
Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome
D C Schoot, T D Pache, W C Hop, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 160) with videos related to
Sort By:
Page
of 16
Human Reproduction (Oxford, England)
|
May 2, 2001
Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development
F P Hohmann, J S Laven, F H de Jong, et al.
Journal of Assisted Reproduction and Genetics
|
April 11, 2001
Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report
D De Jong, E G Van Hooren, N S Macklon, et al.
Clinical Endocrinology
|
November 1, 1992
The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates
B C Fauser, T D Pache, W C Hop, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
July 29, 2009
Diffusion-weighted magnetic resonance imaging in cervical lymphadenopathy: report of three cases of patients with Bartonella henselae infection mimicking malignant disease
D Muenzel, S Duetsch, C Fauser, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 16, 1999
Diagnosis of subtle ovulation disorders in subfertile women with regular menstrual cycles: cost-effective clinical practice?
P van Zonneveld, H P Koppeschaar, J D Habbema, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 16, 1999
Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome
H J Thierry van Dessel, P D Lee, G Faessen, et al.
Acta Endocrinologica
|
August 1, 1993
Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen
D C Schoot, W C Hop, T D Pache, et al.
Endocrinology
|
July 1, 1990
In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines
A B Galway, A J Hsueh, J L Keene, et al.
Human Reproduction (Oxford, England)
|
May 8, 1998
High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization
D de Jong, N S Macklon, B M Mannaerts, et al.
Fertility and Sterility
|
May 1, 1992
Growth patterns of ovarian follicles during induction of ovulation with decreasing doses of human menopausal gonadotropin following presumed selection in polycystic ovary syndrome
D C Schoot, T D Pache, W C Hop, et al.
Page
of 16